I was riding up the lift at Alta the other day and met an investor. He prefers private companies but occassionally dables in public ones. Genitope Corp (GTOP) is one. It just went IPO and is sitting on $37M in cash. It makes $0 revenue and burns through cash at $2M/mth. That means they can cover the next 18 months cost on their phase 3 trial for patient-specific cancer immunotherapy. The only thing I know about biotech is that I should own a few shares. I'd appreciate any feedback you might have after reviewing this company. If it sounds good we can start a GTOP Discussion Board.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar<